Shunfeng Pharmaceutical Transport Phase III Clinical New Crown Vaccine To Sea

Recently, it was reported that in early July, the clinical new crown vaccine developed by Beijing Kexing Zhongwei Biological Technology Co., Ltd. was approved by Brazil's national health supervision agency (Anvisa), and will cooperate with Brazil's Instituto butantan to carry out phase III clinical research. A batch of new crown vaccines for clinical research need to be transported from Beijing to Sao Paulo, Brazil. How to quickly ensure that this batch of clinical vaccines can be safely delivered to Brazil in the shortest time has become the focus of the cooperation.

According to the characteristics of multiple transportation links, transit stop / flight, and ultra long distance, the special team of Shunfeng medicine proposed to use rap with stronger temperature control performance and safety after detailed analysis and demonstration E2 medicine cold chain special aviation container also proposed an end-to-end one-stop service scheme. In less than 2 weeks, both sides quickly determined all the details of the plan. SF pharmaceutical completed the deployment of all domestic and foreign support resources, and safely delivered phase III clinical new crown vaccine to Brazil.

It is understood that SF pharmaceutical is a wholly-owned subsidiary of SF Holding Co., Ltd. It provides three-party pharmaceutical equipment storage, transportation services and scientific and technological services for upstream and downstream enterprises in the pharmaceutical industry chain.

In June this year, Shunfeng pharmaceutical supply chain Hubei Co., Ltd. passed the data review and on-site supervision and inspection by Hubei Provincial Drug Administration, which met the GSP and the third-party logistics enterprise management standards, and had the ability to provide drug storage and transportation logistics services for drug manufacturers and trading enterprises.

It is reported that the drug distribution business of the three parties does not need to pass the drug distribution qualification inspection. Shunfeng pharmaceutical is the first third-party logistics enterprise with this qualification in Hubei Province.